New analyst reports spotlight Oracle's cloud momentum, strategic partnerships and expected fiscal 2026 sales growth.
The pharma and biotech CRM software market presents key growth opportunities in AI-driven CRMs and cloud-based solutions, particularly for SMEs, pharma industries, and emerging markets like Asia ...
Oracle’s stock has come well off its highs, but a Jefferies analyst says concentration and debt concerns are overblown.
Oracle stock dropped -29% in the previous month. You may feel inclined to increase your investment, or you might consider decreasing your exposure.
The Department of Health and Social Care publishes its accounting officer assessment of the NHS Electronic Staff Record ...
Finance operations platform BILL and ERP vendor NetSuite have souped up accounts payable capabilities via Agentic AI, ...
The Daily Overview on MSN
Big Short investor bets $1B against AI and calls out Meta and Oracle
Michael Burry, the investor known for his prescient bet against the housing market in 2008, is now turning his attention to ...
Investment firms for the world’s ultra-wealthy diverged over their stance on Oracle Corp. during a period when the US ...
Michael Burry shut down his hedge fund shortly after disclosing his massive short position. Is he already bracing for a crash ...
Discover why Advanced Micro Devices is a Strong Buy. Click to learn about growth from AI deals, future revenue potential, and ...
Additionally, estimates regarding the impact of AI continue to ratchet higher. The adoption of generative AI could add as ...
Oracle’s rapid OCI cloud and AI growth signal a high-upside phase. Discover projected 27% gains and market drivers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback